Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Turnover, Mineralization, and Volume (TMV) classification at the different timepoints. by Lucas L. A. Nunes (19360381)

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Laboratory parameters and bone mineral density before and after 12 months after DFO. by Lucas L. A. Nunes (19360381)

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Turnover, Mineralization, and Volume (TMV) classification at baseline and 12 months after treatment with DFO. by Lucas L. A. Nunes (19360381)

Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Univariate correlations between serum ferritin, magnetic resonance imaging (MRI), and bone biopsy parameters. by Lucas L. A. Nunes (19360381)

Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

Illustrative MRI of a given patient at baseline and at the end of follow-up. by Lucas L. A. Nunes (19360381)

Patient flow diagram. by Lucas L. A. Nunes (19360381)

Electrocardiographic Abnormalities in Hypertension Models by Ana Gabriela Conceição-Vertamatti (8401224)

Recommendations of no-fly zones for the colonies of common terns, Sandwich terns, black headed gulls, herring gulls and lesser black-backed gulls, great cormorants and Eurasian spo... by Estefania Velilla (22566709)

The U937 cell line was seeded at 2 x 10⁵ cells per well. by Janani Madhuravasal Krishnan (19736002)

S1 Dataset - by Nelmo Jordão Manjate (16324619)

“…For diagnosis by nasal Ag-RDTs, Panbio was MZN 547.00 (USD 8.90), COVIOS was MZN 768.00 (USD 12.50), and LumiraDx was MZN 798.00 (USD 13.00). Medical supplies expenditures represented the main driver of the final cost (>50%), followed by personnel and overhead costs (mean 15% for each). …”